Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
7.75
-0.10
(-1.27%)
At close: February 28 at 8:01:15 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 11 | 21 | 20 |
| Avg. Estimate | 14.43B | 13.54B | 62.97B | 63.19B |
| Low Estimate | 13.94B | 13.2B | 61.1B | 61.32B |
| High Estimate | 15.25B | 13.88B | 64.59B | 65.5B |
| Year Ago Sales | 14.88B | 13.28B | 63.63B | 62.97B |
| Sales Growth (year/est) | -3.03% | 1.91% | -1.03% | 0.35% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PFEB.F | -- | -- | -- | -- |
| S&P 500 | 16.00% | 7.22% | 10.60% | 14.10% |
Related Tickers
BIIB.BA Biogen Inc.
13,125.00
0.00%
IDP.SG Biogen Inc
134.15
-0.26%
NOVN.SW Novartis AG
97.66
+0.05%
AZN.L AstraZeneca PLC
11,968.00
-0.42%
NOVO-B.CO Novo Nordisk A/S
644.50
+0.42%
GILD Gilead Sciences, Inc.
114.31
+2.07%
MRK Merck & Co., Inc.
92.25
+1.84%
JNJ Johnson & Johnson
165.02
+0.79%
LLY Eli Lilly and Company
920.63
+1.71%